30563-98-5

Basic information

• Product Name: 2-Pyridinecarboxylicacid,5-nitro-,ethylester(9CI)
• Synonyms: 2-Pyridinecarboxylicacid,5-nitro-,ethylester(9CI);2-Pyridinecarboxylic acid, 5-nitro-, ethyl ester;ethyl 5-nitropicolinate
• CAS NO: 30563-98-5
• Molecular Formula: C₈H₈N₂O₄
• Molecular Weight: 196.16
• Product Categories: PYRIDINE
• Mol File: 30563-98-5.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 348.3±27.0 °C(Predicted)
• Appearance: /
• Density: 1.317±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: -2.21±0.10(Predicted)
• CAS DataBase Reference: 2-Pyridinecarboxylicacid,5-nitro-,ethylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyridinecarboxylicacid,5-nitro-,ethylester(9CI)(30563-98-5)
• EPA Substance Registry System: 2-Pyridinecarboxylicacid,5-nitro-,ethylester(9CI)(30563-98-5)

Safety Data

• Hazardous Substances Data: 30563-98-5(Hazardous Substances Data)

Usage

Uses

5-Nitro-2-pyridinecarboxylic Acid Ethyl Ester is an intermediate used to prepare 2-(pyridylcarbonyl)cyclohex-1-en-1-ol-3-ones as herbicides.

Upstream product

• 30651-24-2 5-nitropicolinic acid 
• 64-17-5 ethanol 
• 21203-68-9 2-methyl-5-nitropyridine 
• 4548-45-2 2-chloro-5-nitropyridine 
• 4487-59-6 2-bromo-5-nitropyridine 

Downstream Products

• 1197332-86-7 6-[4-(4-methoxy-benzyl)-3,3-dimethyl-piperazin-1-ylmethyl]-pyridin-3-ylamine 
• 1197332-88-9 1-(4-methoxy-benzyl)-2,2-dimethyl-4-(5-nitro-pyridin-2-ylmethyl)-piperazine 
• 1180132-76-6 6-((4-methylpiperazin-1-yl)methyl)pyridin-3-amine 
• 36625-57-7 (5-nitropyridin-2-yl)methanol 
• 35969-75-6 5-nitro-2-pyridinecarbaldehyde 
• 90866-95-8 ethyl 5-(N-acetyl-p-toluenesulfonamido)picolinate 
• 90866-96-9 ethyl N-ethyl-5-(p-toluenesulfonamido)pipecolate 
• 90866-93-6 ethyl 5-(p-toluenesulfonamido)picolinate 
• 119830-47-6 ethyl 3-amino-pyridine-6-carboxylate 

Relevant articles and documents

JAK1 SELECTIVE KINASE INHIBITOR

Disclosed herein are compounds of Formula (I), and pharmaceutically acceptable salts thereof, that are useful as JAK kinase inhibitors. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula (I), and methods of using such compounds or compositions to treat respiratory conditions (e.g., asthma or COPD).

Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and methods for their use

Compounds represented by the Formula (I): are described. The compounds and pharmaceutical compositions containing them may be used in inhibiting and/or modulating protein kinases, in treating or preventing diseases associated with protein kinases, and/or in treating or preventing cellular proliferative diseases.

Synthesis of DL-slaframine

-